查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1198361

智能隐形眼镜市场 - 增长、趋势、COVID-19 影响和预测 (2023-2028)

Smart Contact Lenses Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 111 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计在 2022 年至 2027 年的预测期内，智能隐形眼镜市场的复合年增长率为 9.8%。

由于眼科就诊人数减少，COVID-19 对 2020 年智能隐形眼镜市场增长的影响不利。 例如，根据美国疾病控制与预防中心和美国眼科学会在 2020 年 8 月发布的数据，最初眼科就诊人数下降了近 80%。 截至6月中旬，美国的眼科医生就诊人数累计下降了40%。 然而，随着眼科保健在全球范围内重新开放，在不久的将来可能会恢復正常增长率。 例如，根据 2020 年 6 月在印度发表的一篇文章“COVID-19 后的远程会诊-建议的临床眼科指南”，卫生和家庭福利部建议眼科保健机构减少患者对拟议指南的就诊次数在 COVID-19 情况下进行安全的眼科护理，包括在美国鼓励远程咨询和远程咨询，并允许需要测试、眼科检查或程序的患者根据预约系统进行呼叫。 同样，2020 年 3 月，美国眼科学会 (AAO) 发布了临床实践指南，建议眼科医生停止非紧急护理。 预计这些因素将增加患者人群对智能隐形眼镜的需求，从而导致未来几年的市场增长。

此外，推动市场增长的主要因素是眼科疾病负担的加重、老花眼在老龄化人群中的患病率增加、青光眼治疗技术的进步激增以及智能接触的主要市场镜头製造，一个例子是关联方的研发活动活跃起来。

智能隐形眼镜通过测量眼泪中的葡萄糖水平和监测眼内压来诊断糖尿病和青光眼。 因此，导致眼睛受损的糖尿病负担日益增加，预计将推动对智能隐形眼镜的需求，从而显着促进市场增长，例如 2021 年 11 月宣布的全球糖尿病视网膜病变患病率和预测。到 2045 年的负担：系统性Review and Meta-Analysis”，在糖尿病患者中，全球患病率为 22.27%。 27%，威胁视力的 DR (VTDR) 6.17%，临床显着的黄斑水肿 4.07%。 此外，根据 2021 年 7 月发表的题为“过去 20 年原发性开角型青光眼的患病率：一项荟萃分析和系统评价”的论文，过去 20 年原发性开角型青光眼（POAG）呈现了最新的全球患病率 根据这项研究的结果，POAG 在 40 岁以上人群中的全球患病率为 2.4%。 此外，根据2022年3月的最新消息，在韩国，由Seikwang Han教授和博士领导的POSTECH研究团队开发了一种智能隐形眼镜型可穿戴终端，它可以用LED光照射视网膜，以防止和早期治疗糖尿病视网膜病变。 这种智能 LED 隐形眼镜技术因治疗各种眼部疾病而备受关注。

因此，由于上述因素，眼科疾病负担的增加和智能隐形眼镜技术的进步预计将在预测期内推动对智能隐形眼镜的需求。

然而，智能隐形眼镜的高成本和智能隐形眼镜的认知度低是製约市场增长的主要因素。

智能隐形眼镜市场趋势

在智能隐形眼镜市场，持续血糖监测细分市场有望占据较大市场份额

按应用来看，连续血糖监测领域预计将占据很大的市场份额。 智能隐形眼镜旨在通过持续测量眼泪中的葡萄糖水平来帮助糖尿病患者。 这些镜片中嵌入了微型传感器和无线芯片，以跟踪糖尿病患者的眼压等生理因素。 传感器嵌入两层软镜片中。 外层的小开口允许眼泪流入传感器，传感器检测血糖水平并将数据传输到无线设备进行存储。 通过这种方式，实时监测血糖水平可以帮助制定有关饮食、身体活动和药物平衡的日常决策。

推动这一细分市场增长的主要因素包括研发活动的增加、眼科领域的技术进步以及糖尿病患者越来越多地采用智能隐形眼镜。 根据 2021 年 6 月发表的“Current Approaches and Future Perspectives”，最近开发的用于生物医学目的的智能隐形眼镜已与持续血糖监测和治疗糖尿病视网膜病变的按需灵活药物联繫在一起。似乎它兼具两者交付系统。

研发活动的增加也促进了这一细分市场的增长。 例如，在 2020 年 4 月一篇题为“用于糖尿病诊断和治疗的无线智能隐形眼镜”的文章中，研究人员报导了使用智能隐形眼镜进行持续血糖监测和糖尿病视网膜病变治疗的研究，据说已经开发出来。 根据这项研究，基于生物相容性聚合物的智能隐形眼镜设备包括超薄和柔性电路，以及实时电化学生物传感、按需控製药物输送、无线电源管理和数据通信。包含微控制器芯片为了 此外，该设备能够测量通过传统侵入式血糖测试验证的泪液葡萄糖水平。 这些研究强调了智能隐形眼镜在连续血糖监测中的重要性。 因此，更多取得积极成果的研究会导致产品获得批准，这反过来又有助于该细分市场在未来一段时间内的增长。

因此，由于上述发展，预计该细分市场在预测期内将出现显着增长。

预计北美将占据全球市场的最大份额

预计北美将占据很大的市场份额。 这可以归因于诸如寻求眼科护理的患者增加、产品营销意识提高、研发活动增加以及市场参与者在该地区的强大影响力等因素。

例如，根据 BrightFocus 基金会 2021 年 7 月的更新，超过 300 万美国人患有青光眼，其中 270 万 40 岁以上的人患有最常见的开角型青光眼。据说他患有角性青光眼。 青光眼也是美国非裔美国人和西班牙裔美国人失明的主要原因。 因此，大量青光眼患者将增加该地区对智能隐形眼镜的需求，最终将促进市场增长。

此外，知名企业采取的几项战略举措也为市场增长做出了贡献。 例如，2021 年 1 月，专门将微电子技术嵌入水凝胶设备的公司 InWith 将在 CES 活动 2021 上展示令人惊嘆的智能隐形眼镜，并将在软性隐形眼镜中展示增强现实 (AR)，从而打开一扇新的大门计算机化应用的未来。

因此，由于上述因素，市场预计在预测期内将出现显着增长。

智能隐形眼镜市场竞争对手分析

智能隐形眼镜市场竞争激烈，有多家全球和国际参与者。 主要参与者正在采用各种增长战略，例如合作伙伴关係、协议、合作、新产品发布、地域扩张、兼併和收购，以增加他们在市场上的影响力。 该市场的主要参与者包括 Sensimed、Mojo Vision、Innovega Inc.、InWith Corporation、强生等市场参与者。

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第1章介绍

  • 研究假设和市场定义
  • 调查范围

第2章研究方法论

第 3 章执行摘要

第4章市场动态

  • 市场概览
  • 市场驱动力
    • 眼病负担加重
    • 增加智能隐形眼镜的研发
  • 市场製约因素
    • 智能隐形眼镜成本高，认知度低
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（基于价值的市场规模：百万美元）

  • 按类型
    • 刚性透气性 (RGP)
    • 日戴软镜片
    • 长戴镜片
    • 其他
  • 通过申请
    • 连续血糖监测
    • 连续眼压测量
  • 最终用户
    • 医院
    • 眼科诊所
    • 其他最终用户
  • 按地区
    • 北美
    • 欧洲
    • 亚太地区
    • 中东
    • 南美洲

第6章竞争格局

  • 公司简介
    • Sensimed
    • Mojo Vision
    • Innovega Inc.
    • InWith Corporation
    • Johnson & Johnson
    • Samsung
    • Sony Group Corporation
    • EP Global Communications Inc（EPGL）
    • International Business Machines（IBM）Corporation
    • Huawei Biomed
    • RaayonNova LLC

第7章 市场机会与今后动向

简介目录
Product Code: 90543

The Smart Contact Lenses Market is expected to register a CAGR of 9.8% over the forecast period, 2022-2027.

The impact of COVID-19 on the smart contact lenses market's growth was adverse in 2020 due to fewer eye care consultations. For instance, according to data published in August 2020 by the Centers for Disease Control and Prevention and the American Academy of Ophthalmology, there was a nearly 80% initial decrease in ophthalmology visits. As of mid-June, there was still a 40% cumulative decrease in ophthalmology visits in the United States. However, owing to the recommencement of ophthalmology practices and procedures worldwide, the market may soon prevail with a normal growth rate. For instance, according to the article "Tele-consultations in the wake of COVID-19 - Suggested guidelines for clinical ophthalmology," published in June 2020 in India, the Ministry of Health and Family Welfare proposed guidelines for safe ophthalmology practices in the COVID-19 scenario, such as eye care facilities should ensure that telecounseling and teleconsultation should be encouraged to reduce patient visits and appointment systems can be followed to call patients needing examinations, eye investigations, or procedures. Likewise, in March 2020, the American Academy of Ophthalmology (AAO) released practice guidelines advising ophthalmologists to cease providing any treatment other than urgent and emergent care. Such factors are projected to boost the demand for smart contact lenses among the patient population, thereby leading to market growth over the coming years.

Furthermore, the major factors fuelling the market's growth are the rising burden of eye disorders, the growing prevalence of presbyopia in the geriatric population, the surge in advancements in glaucoma treatment technologies, and the increasing research and development activities by key market players for smart contact lens manufacturing.

Smart contact lenses diagnose diabetes and glaucoma by measuring the glucose level in tears and monitoring intraocular pressure within the eyes. The rising burden of diabetes, leading to eye disorders, is thus expected to drive the demand for smart contact lenses, thereby significantly contributing to the market growth, for instance, as per a November 2021 published article titled, "Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045: Systematic Review and Meta-analysis", among individuals with diabetes, the global prevalence was 22.27% for diabetic retinopathy, 6.17% for vision-threatening DR (VTDR), and 4.07% for clinically significant macular edema. In addition, as per a July 2021 published article titled, "Prevalence of primary open-angle glaucoma in the last 20 years: a meta-analysis and systematic review", the study provided the most updated worldwide prevalence of primary open-angle glaucoma (POAG) for the last 20 years. As per the study results, the overall global prevalence of POAG in the population over 40 years old is 2.4%. Moreover, according to a March 2022 update, in South Korea, a POSTECH research team led by Professor Sei Kwang Hahn and Ph.D. candidate Geon-Hui Lee, in collaboration with Dr. Sangbaie Shin of PHI BIOMED Co., developed a smart contact lens-type wearable device to prevent diabetic retinopathy and treat it in its early stages by irradiating 120 µW far-red/LED light to the retina. This technology for smart LED contact lenses has attracted great attention for various ophthalmologic diseases.

Thus, the abovementioned factors indicate that the growing burden of eye disorders and advancements in smart contact lens technology will drive the demand for smart contact lenses over the forecast period.

However, the high cost of smart contact lenses and lack of awareness about these lenses are the major factors restraining the market's growth.

Smart Contact Lenses Market Trends

Continuous Glucose Monitoring Segment is Expected to Hold a Significant Market Share in the Smart Contact Lenses Market

By application, the continuous glucose monitoring segment is expected to hold a significant share in the market. The smart contact lens aims to help diabetes patients by continuously measuring the glucose level in their tears. Miniaturized sensors and wireless chips are built into these lenses to track physiological factors such as intraocular pressure in people with diabetes. Sensors are embedded in the two layers of soft lenses. A small opening in the outer layer allows tears to flow into the sensor, which detects blood sugar levels and transmits the data to the wireless device for storage. Thus, monitoring glucose levels in real-time aids in making informed daily decisions about balancing food, physical activity, and medicine.

The major factors fuelling the segment's growth are an increase in research and development activities, technological advancements in the field of ophthalmology, and the growing adoption of smart contact lenses among the diabetic population, for instance, as per an article titled "Continuous Non-Invasive Glucose Monitoring via Contact Lenses: Current Approaches and Future Perspectives" published in June 2021, recent advances in the development of smart contact lenses for biomedical purposes combine both continuous glucose monitoring with an on-demand flexible drug delivery system for the treatment of diabetic retinopathy.

In addition, increasing research and development activities contribute to the segment's growth. For instance, as per an April 2020 published article titled "Wireless smart contact lens for diabetic diagnosis and therapy," the researchers developed smart contact lenses for continuous glucose monitoring and treating diabetic retinopathy. As per the study, the smart contact lens device, built on a biocompatible polymer, contains ultrathin, flexible electrical circuits, and a microcontroller chip for real-time electrochemical biosensing, on-demand controlled drug delivery, wireless power management, and data communication. Additionally, the study states that the device could measure tear glucose levels to be validated by conventional invasive blood glucose tests. Such studies highlight the significance of smart contact lenses in continuous glucose monitoring. Thus, more studies with positive outcomes are leading to product approvals, which, in turn, contribute to the segment's growth over the coming period.

Thus, due to the abovementioned developments, the segment is expected to witness significant growth over the forecast period.

North America is Expected to Hold the Largest Share in the Global Market

North America is expected to hold a significant share of the market. It can be attributed to factors such as the increasing number of patient visits seeking eye care treatment, a surge in awareness regarding the commercial availability of products, a rising number of research and development activities, and the strong presence of market players in the region.

For instance, as per a July 2021 update by the BrightFocus Foundation, more than three million Americans are living with glaucoma, 2.7 million of whom aged 40 and older are affected by its most common form, open-angle glaucoma. As per the same source, glaucoma is a leading cause of blindness among African Americans and Hispanics in the United States. Thus, the high number of people suffering from glaucoma will likely increase the demand for smart contact lenses within the region, ultimately contributing to market growth.

Additionally, several strategic initiatives undertaken by prominent players are contributing to the market's growth. For instance, in January 2021, InWith, a corporation that specializes in the embedding of microelectronic technology in hydrogel devices, demonstrated its incredible smart contact lenses at the CES event 2021, opening a new door for the future of computerized applications for augmented reality (AR) in soft contact lenses.

Thus, owing to the abovementioned factors, the market is expected to witness significant growth over the forecast period.

Smart Contact Lenses Market Competitor Analysis

The smart contact lenses market is competitive with several global and international players. The key players are adopting different growth strategies to enhance their market presence, such as partnerships, agreements, collaborations, new product launches, geographical expansions, mergers, and acquisitions. Some of the key players in the market are Sensimed, Mojo Vision, Innovega Inc., InWith Corporation, and Johnson & Johnson, among other market players.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Burden of Eye Disorders
    • 4.2.2 Increasing Research and Development for Smart Contact Lenses
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Smart Contact Lenses and Lack of Awareness
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Type
    • 5.1.1 Rigid Gas-Permeable (RGP)
    • 5.1.2 Daily-wear Soft Lenses
    • 5.1.3 Extended-wear Lenses
    • 5.1.4 Others
  • 5.2 By Application
    • 5.2.1 Continuous Glucose Monitoring
    • 5.2.2 Continuous Intraocular Pressure Monitoring
  • 5.3 By End User
    • 5.3.1 Hospitals
    • 5.3.2 Ophthalmology Clinics
    • 5.3.3 Other End Users
  • 5.4 Geography
    • 5.4.1 North America
    • 5.4.2 Europe
    • 5.4.3 Asia-Pacific
    • 5.4.4 Middle-East
    • 5.4.5 South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Sensimed
    • 6.1.2 Mojo Vision
    • 6.1.3 Innovega Inc.
    • 6.1.4 InWith Corporation
    • 6.1.5 Johnson & Johnson
    • 6.1.6 Samsung
    • 6.1.7 Sony Group Corporation
    • 6.1.8 EP Global Communications Inc (EPGL)
    • 6.1.9 International Business Machines (IBM) Corporation
    • 6.1.10 Huawei Biomed
    • 6.1.11 RaayonNova LLC

7 MARKET OPPORTUNITIES AND FUTURE TRENDS